Digital Diabetes Management Market Size, Share, Trend Report 2026 to 2035
What is Digital Diabetes Management Market Size?
Global Digital Diabetes Management Market Size is valued at USD 23.01 Bn in 2025 and is predicted to reach USD 83.65 Bn by the year 2035 at a 13.9% CAGR during the forecast period for 2026 to 2035.
Digital Diabetes Management Market Size, Share & Trends Analysis Report By Product Type (Devices, Digital Diabetes Management Apps & Software Platforms, Data Management & Decision Support Tools, services), By End User (Hospitals & Clinics, Home Care / Self-Management Users, Diagnostic Centres & Laboratories, Academic & Research Institutes), By Device Type (Wearable Devices , Handheld Devices ,Mobile & Cloud-Based Platforms), By Sales / Distribution Channel, By Region and By Segments Forecasts, 2026 to 2035.
Digital Diabetes Management Market Key Takeaways:
|
Key Industry Insights & Findings from the Report:
- New digital apps that use augmented and virtual reality to monitor blood glucose levels are driving the growth of the digital diabetes management industry.
- The increasing prevalence of diabetes has magnified the importance of the demand for improved diabetes care solutions.
- North America dominated the market and accounted for a revenue share of global revenue in 2024.
- The industry is expected to be constrained by a lack of knowledge about digital diabetes treatment in developing nations.
A collection of programs known as diabetes management software can assist patients and healthcare professionals track and monitor their diabetes. Diabetes management software is gaining popularity for various applications in the healthcare sector thanks to its multiple mobile and desktop apps, propelling growth in the diabetes management software market. To measure, monitor, and manage the degree of diabetes, diabetes management software is available for use on personal computers, mobile phones, tablets, and other digital assistants.
The market is expanding due to the adoption of diabetes awareness programs and other measures by various governments. These businesses' media efforts and initiatives for treating and preventing diabetes aid in raising public knowledge of the presence of multiple technologies in this industry. Diabetic patients have a high need for continuous blood glucose monitoring, which will significantly impact the growth of the global market over the forecast period. The market is estimated to face challenges in the future due to the growth in data security concerns and lower penetration in developing countries.
As there was a high risk of contracting COVID, the market for digital technologies for disease management among diabetes patients was growing. The product was created and planned to give patients a customized insight into how their blood sugar levels will respond to their diet, insulin dosage, and daily schedule. Therefore, the adoption and accessibility of such cutting-edge, rising, and unique technologies in the field of digital diabetes management would enhance market growth during the projection period.
Competitive Landscape
Some major key players in the Global Digital Diabetes Management Market:
- Abbott Laboratories
- Dexcom, Inc.
- Medtronic plc
- Insulet Corporation
- Roche Diabetes Care (Roche Diagnostics)
- Ascensia Diabetes Care Holdings AG
- Tandem Diabetes Care, Inc.
- Glooko, Inc.
- Novo Nordisk A/S
- Senseonics Holdings, Inc.
- Sanofi S.A.
- B. Braun Melsungen AG
- Bayer AG
- LifeScan, Inc. (active but under financial restructuring)
- Omada Health, Inc.
- One Drop, Inc.
- Lark Health
- Noom, Inc.
- Tidepool, Inc.
- HealthifyMe Wellness Pvt. Ltd.
- Virta Health Corp.
- Glytec, Inc.
- DreaMed Diabetes Ltd.
- DarioHealth Corp.
- Others
Market Segmentation:
The digital diabetes management market is divided into product & service, application, device type and end-use. Based on products & services, the market is segmented into devices (smart glucose meters, continuous glucose monitoring systems, and smart insulin pens, smart insulin pumps/ closed-loop pumps & smart insulin patches), application (diabetes & blood glucose tracking apps, obesity & diet management apps), data management software & platforms and services. The digital diabetes management market is segmented based on the device type into handheld and wearable devices. Based on end-use, the digital diabetes management market is divided into self/home healthcare, hospitals & speciality diabetes clinics and academic & research institutes.
Based on end users, the self/home healthcare segment is a major contributor to the digital diabetes management market.
The market's leading segment is self/home healthcare. The devices available on the market have an intuitive user interface coupled with cutting-edge digital gadgets. Adoption of these devices is becoming more necessary as patient awareness of diabetes management rises. This market is anticipated to grow due to the devices' use in exchanging crucial information with professionals via digital platforms. The market is anticipated to become less active due to widespread access to professionals in home healthcare. Due to the conditions, there was a high demand for digital diabetes management tools in the home settings market during the pandemic. During the pandemic, this sector received a significant boost from people using mobile applications and other connected devices at home.
The continuous glucose monitoring segment witnessed growth at a rapid rate.
Continuous glucose monitoring grabbed the highest revenue share, and it is anticipated that they will continue to hold that position during the anticipated time due to factors including ongoing technological development, rising product launches, greater incorporation of remote monitoring technologies into devices, rising availability of these gadgets, and increasing public awareness. Abbott established a freestyle libre system by enhancing its services in this industry. The use of this device will assist in tracking a patient's real-time blood glucose readings. Additionally, it gives a thorough picture of each person's glucose levels.
The North American digital diabetes management market holds a significant regional revenue share.
The North American digital diabetes management market is expected to register the highest market share. Numerous reasons, including the emphasis on ongoing technical breakthroughs, impending product launches with cutting-edge features, and the presence of significant market players in the North American region, have contributed to this region's success. The region's rising diabetic patient population provides growth prospects for the key market participants. Additionally, Asia Pacific is anticipated to increase quickly in the coming years. This market is expected to grow due to various factors, including an increase in the number of individuals with diabetes, growing healthcare costs, and an increasing number of market competitors in the area. It is also anticipated that rising disposable income and increased public knowledge of diabetes and other related health issues will promote the development of this industry.
Recent Developments:
- In May 2024, Dexcom has introduced the Dexcom ONE+ continuous glucose monitor (CGM) in the UK. ONE+ utilized Dexcom's preexisting sensor design, adding input from users and healthcare experts during the development process. The organization affirmed that this guaranteeed a user-friendly and exceptionally efficient continuous glucose monitoring (CGM) experience for individuals managing type 2 or type 1 diabetes with insulin.
Global Digital Diabetes Management Market Report Scope :
| Report Attribute | Specifications |
| Market Size Value In 2025 | USD 23.01 Billion |
| Revenue Forecast In 2035 | USD 83.65 Billion |
| Growth Rate CAGR | CAGR of 13.9% from 2026 to 2035 |
| Quantitative Units | Representation of revenue in US$ Mn, and CAGR from 2026 to 2035 |
| Historic Year | 2022 to 2024 |
| Forecast Year | 2026-2035 |
| Report Coverage | The forecast of revenue, the position of the company, the competitive market structure, growth prospects, and trends |
| Segments Covered | Product Type, Device Type , End User and Sales / Distribution Channel. |
| Regional Scope | North America; Europe; Asia Pacific; Latin America; Middle East & Africa |
| Country Scope | U.S.; Canada; U.K.; Germany; China; India; Japan; Brazil; Mexico ;The UK; France; Italy; Spain; China; Japan; India; South Korea; South East Asia; South Korea; South East Asia |
| Competitive Landscape | Abbott Laboratories, Dexcom, Inc., Medtronic plc, Insulet Corporation, Roche Diabetes Care (Roche Diagnostics), Ascensia Diabetes Care Holdings AG, Tandem Diabetes Care, Inc., Glooko, Inc., Novo Nordisk A/S, Senseonics Holdings, Inc., Sanofi S.A., B. Braun Melsungen AG, Bayer AG, LifeScan, Inc. (active but under financial restructuring), Omada Health, Inc., One Drop, Inc., Lark Health, Noom, Inc., Tidepool, Inc., HealthifyMe Wellness Pvt. Ltd., Virta Health Corp., Glytec, Inc., DreaMed Diabetes Ltd., DarioHealth Corp., Others |
| Customization Scope | Free customization report with the procurement of the report, Modifications to the regional and segment scope. Particular Geographic competitive landscape. |
| Pricing And Available Payment Methods | Explore pricing alternatives that are customized to your particular study requirements. |
Segmentation of Digital Diabetes Management :
Digital Diabetes Management Market By Product Type-
- Devices
- Continuous Glucose Monitoring (CGM) Systems
- Smart Glucose Meters
- Smart Insulin Pens
- Smart Insulin Pumps
- Digital Diabetes Management Apps & Software Platforms
- Data Management & Decision Support Tools
- services
Digital Diabetes Management Market By Device Type-
- Wearable Devices
- Handheld Devices
- Mobile & Cloud-Based Platforms
Digital Diabetes Management Market By End User-
- Hospitals & Clinics
- Home Care / Self-Management Users
- Diagnostic Centers & Laboratories
- Academic & Research Institutes
Digital Diabetes Management Market By Sales / Distribution Channel-
- Retail / Pharmacy Sales
- Online / E-commerce Platforms
- Distributor Sales
Digital Diabetes Management Market By Region-
North America-
- The US
- Canada
- Mexico
Europe-
- Germany
- The UK
- France
- Italy
- Spain
- Rest of Europe
Asia-Pacific-
- China
- Japan
- India
- South Korea
- South East Asia
- Rest of Asia Pacific
Latin America-
- Brazil
- Argentina
- Rest of Latin America
Middle East & Africa-
- GCC Countries
- South Africa
- Rest of Middle East and Africa
Research Design and Approach
This study employed a multi-step, mixed-method research approach that integrates:
- Secondary research
- Primary research
- Data triangulation
- Hybrid top-down and bottom-up modelling
- Forecasting and scenario analysis
This approach ensures a balanced and validated understanding of both macro- and micro-level market factors influencing the market.
Secondary Research
Secondary research for this study involved the collection, review, and analysis of publicly available and paid data sources to build the initial fact base, understand historical market behaviour, identify data gaps, and refine the hypotheses for primary research.
Sources Consulted
Secondary data for the market study was gathered from multiple credible sources, including:
- Government databases, regulatory bodies, and public institutions
- International organizations (WHO, OECD, IMF, World Bank, etc.)
- Commercial and paid databases
- Industry associations, trade publications, and technical journals
- Company annual reports, investor presentations, press releases, and SEC filings
- Academic research papers, patents, and scientific literature
- Previous market research publications and syndicated reports
These sources were used to compile historical data, market volumes/prices, industry trends, technological developments, and competitive insights.
Primary Research
Primary research was conducted to validate secondary data, understand real-time market dynamics, capture price points and adoption trends, and verify the assumptions used in the market modelling.
Stakeholders Interviewed
Primary interviews for this study involved:
- Manufacturers and suppliers in the market value chain
- Distributors, channel partners, and integrators
- End-users / customers (e.g., hospitals, labs, enterprises, consumers, etc., depending on the market)
- Industry experts, technology specialists, consultants, and regulatory professionals
- Senior executives (CEOs, CTOs, VPs, Directors) and product managers
Interview Process
Interviews were conducted via:
- Structured and semi-structured questionnaires
- Telephonic and video interactions
- Email correspondences
- Expert consultation sessions
Primary insights were incorporated into demand modelling, pricing analysis, technology evaluation, and market share estimation.
Data Processing, Normalization, and Validation
All collected data were processed and normalized to ensure consistency and comparability across regions and time frames.
The data validation process included:
- Standardization of units (currency conversions, volume units, inflation adjustments)
- Cross-verification of data points across multiple secondary sources
- Normalization of inconsistent datasets
- Identification and resolution of data gaps
- Outlier detection and removal through algorithmic and manual checks
- Plausibility and coherence checks across segments and geographies
This ensured that the dataset used for modelling was clean, robust, and reliable.
Market Size Estimation and Data Triangulation
Bottom-Up Approach
The bottom-up approach involved aggregating segment-level data, such as:
- Company revenues
- Product-level sales
- Installed base/usage volumes
- Adoption and penetration rates
- Pricing analysis
This method was primarily used when detailed micro-level market data were available.
Top-Down Approach
The top-down approach used macro-level indicators:
- Parent market benchmarks
- Global/regional industry trends
- Economic indicators (GDP, demographics, spending patterns)
- Penetration and usage ratios
This approach was used for segments where granular data were limited or inconsistent.
Hybrid Triangulation Approach
To ensure accuracy, a triangulated hybrid model was used. This included:
- Reconciling top-down and bottom-up estimates
- Cross-checking revenues, volumes, and pricing assumptions
- Incorporating expert insights to validate segment splits and adoption rates
This multi-angle validation yielded the final market size.
Forecasting Framework and Scenario Modelling
Market forecasts were developed using a combination of time-series modelling, adoption curve analysis, and driver-based forecasting tools.
Forecasting Methods
- Time-series modelling
- S-curve and diffusion models (for emerging technologies)
- Driver-based forecasting (GDP, disposable income, adoption rates, regulatory changes)
- Price elasticity models
- Market maturity and lifecycle-based projections
Scenario Analysis
Given inherent uncertainties, three scenarios were constructed:
- Base-Case Scenario: Expected trajectory under current conditions
- Optimistic Scenario: High adoption, favourable regulation, strong economic tailwinds
- Conservative Scenario: Slow adoption, regulatory delays, economic constraints
Sensitivity testing was conducted on key variables, including pricing, demand elasticity, and regional adoption.
Request Customization
Add countries, segments, company profiles, or extend forecast — free 10% customization with purchase.
Customize This Report →Enquire Before Buying
Speak with our analyst team about scope, methodology, pricing, or deliverable formats.
Enquire Now →Frequently Asked Questions
Digital Diabetes Management Market Size is valued at USD 23.01 Bn in 2025 and is predicted to reach USD 83.65 Bn by the year 2035.
Digital Diabetes Management Market is expected to grow at an 13.9% CAGR during the forecast period for 2026-2035.
Abbott Laboratories, Dexcom, Inc., Medtronic plc, Insulet Corporation, Roche Diabetes Care (Roche Diagnostics), Ascensia Diabetes Care Holdings AG, Tandem Diabetes Care, Inc., Glooko, Inc., Novo Nordisk A/S, Senseonics Holdings, Inc., Sanofi S.A., B. Braun Melsungen AG, Bayer AG, LifeScan, Inc. (active but under financial restructuring), Omada Health, Inc., One Drop, Inc., Lark Health, Noom, Inc., Tidepool, Inc., HealthifyMe Wellness Pvt. Ltd., Virta Health Corp., Glytec, Inc., DreaMed Diabetes Ltd., DarioHealth Corp. and Others
Product Type, Device Type , End User and Sales / Distribution Channel are the key segments of the Digital Diabetes Management Market. self/home healthcare, hospitals & speciality diabetes clinics and academic & research institutes.
North America region is leading the Digital Diabetes Management Market.